Mangoceuticals, Inc.MGRXNASDAQ
LOADING
|||
Operating Income Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-43.17%
↑ 70% above average
Average (15q)
-145.16%
Historical baseline
Range
High:32.26%
Low:-1652.55%
Volatility
-1160.7%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -43.17% |
| Q2 2025 | -8.56% |
| Q1 2025 | -189.22% |
| Q4 2024 | 4.55% |
| Q3 2024 | 18.94% |
| Q2 2024 | 8.40% |
| Q1 2024 | 7.80% |
| Q4 2023 | -42.75% |
| Q3 2023 | 21.52% |
| Q2 2023 | 10.43% |
| Q1 2023 | -280.90% |
| Q4 2022 | 32.26% |
| Q3 2022 | -202.48% |
| Q2 2022 | -1652.55% |
| Q1 2022 | -6.79% |
| Q4 2021 | 0.00% |